CivicaScript™, SortPak partner to package & deliver medicines to maximize patient convenience, compliance and savings

CivicaScript^TM, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and SortPak, which delivers pre-sorted medications to patients at no extra cost to patients or health plans, are partnering to provide CivicaScript medicines in packaging designed to maximize patient convenience, savings and medication compliance.

SortPak offers two packaging options to make it easier for patients to take medicines as prescribed:

SortPak, which individually packages each dose based on the time and day patients take their medicines.
SyncPak, which synchronizes refills of patients’ medicines and delivers them in one box to their doorsteps.

The first medication the two companies will deliver together is CivicaScript’s treatment for prostate cancer. SortPak, a URAC- and ACHC-accredited specialty pharmacy, is especially knowledgeable in managing the needs of people with cancer.

Other medications will follow as part of the collaboration, including affordable insulin.

“This partnership builds on our mission to make generic medicines affordable and available to everyone,” said CivicaScript President Gina Guinasso. “Lowering the cost of medicines while enhancing patient compliance and convenience is a win for patients.”

“We’re proud to join CivicaScript to make taking your medicine simple, convenient and more affordable,” said SortPak Co-Founders Raymond Shirvanyan and Jack Simityan. “This whole-health model is truly the future of health care.”

SortPak’s value-based care model provides a unique hybrid pharmacy service to health plan members by offering a one-stop pharmacy for both maintenance and specialty medications.

This model is designed to maximize medication adherence by:

Creating a routine for daily medication consumption.
Providing free delivery of all medicines.
Syncing all medicines to one date for a 90-day supply.
Processing refills and arranging delivery ahead of time.
Sorting doses into pouches according to the day and time they should be taken.

SortPak’s services come at no extra cost for members or health plans.

Virginia Catalyst Announces Round 19 of Grant Funding

The Virginia Catalyst announced today that it is accepting letters of intent (LOI) for Grant Round 19 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “We at the Virginia Catalyst are pleased to provide funding in support of the Governor’s …

10/21/2025

SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers

SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been awarded up to $34 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop technology as part of the POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in Oncology) program. This pioneering program …

10/21/2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, QRX003, for the treatment of Netherton Syndrome. The designation follows previously granted Orphan …

News